National Bank of Canada’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.8K | Buy |
+9,000
| New | +$23.8K | ﹤0.01% | 1798 |
|
|
2025
Q1 | – | Sell |
-490,300
| Closed | -$1.26M | – | 2598 |
|
|
2024
Q4 | $1.26M | Buy |
490,300
+405,900
| +481% | +$1.04M | ﹤0.01% | 1002 |
|
|
2024
Q3 | $314K | Sell |
84,400
-178,900
| -68% | -$666K | ﹤0.01% | 1136 |
|
|
2024
Q2 | $1.65M | Buy |
263,300
+207,989
| +376% | +$1.3M | ﹤0.01% | 860 |
|
|
2024
Q1 | $449K | Buy |
+55,311
| New | +$449K | ﹤0.01% | 1101 |
|
|
2023
Q4 | – | Sell |
-699,300
| Closed | -$1.07M | – | 2583 |
|
|
2023
Q3 | $1.07M | Sell |
699,300
-96,100
| -12% | -$147K | ﹤0.01% | 1004 |
|
|
2023
Q2 | $2.18M | Buy |
795,400
+663,300
| +502% | +$1.82M | ﹤0.01% | 867 |
|
|
2023
Q1 | $240K | Hold |
132,100
| – | – | ﹤0.01% | 1254 |
|
|
2022
Q4 | $670K | Buy |
132,100
+130,300
| +7,239% | +$661K | ﹤0.01% | 1080 |
|
|
2022
Q3 | $9K | Hold |
1,800
| – | – | ﹤0.01% | 2038 |
|
|
2022
Q2 | $7K | Hold |
1,800
| – | – | ﹤0.01% | 2143 |
|
|
2022
Q1 | $10K | Hold |
1,800
| – | – | ﹤0.01% | 2146 |
|
|
2021
Q4 | $11K | Buy |
+1,800
| New | +$11K | ﹤0.01% | 2098 |
|